A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

NCT05321082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1178

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases, Interstitial

Interventions

DRUG: BI 1015550
DRUG: Placebo

Sponsor

Boehringer Ingelheim